Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07393503

Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries

Status
Enrolling By Invitation
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
State University of New York at Buffalo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this pilot study, the investigators aim to compare two short-term pain relief methods administered over the course of 6 days in the setting of acute musculoskeletal (MSK) pain: 1. Methylprednisolone((Medrol)dose pack- standard taper per dose pack instructions 2. Standard of Care (SOC) which includes a combination of Acetaminophen (Tylenol)+Ibuprofen (Motrin) The investigators are interested in studying pain relief regimens for acute injury of any body part among an adult orthopaedic urgent care population.

Conditions

Interventions

TypeNameDescription
DRUGMethylprednisolone 4Mg TabParticipants follow standard 6- day taper dosing schedule.
DRUGAcetaminophen 500Mg TabParticipants follow a 6- day taper dosing schedule.
DRUGIbuprofen 200Mg Oral TabletParticipants follow a 6- day taper dosing schedule.

Timeline

Start date
2025-09-17
Primary completion
2026-08-01
Completion
2027-01-01
First posted
2026-02-06
Last updated
2026-02-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07393503. Inclusion in this directory is not an endorsement.